You do not have permission to edit this page, for the following reasons:

This IP address has been blocked from editing Wikipedia.
This does not affect your ability to read Wikipedia pages.
Most people who see this message have done nothing wrong. Some kinds of blocks restrict editing from specific service providers or telecom companies in response to recent abuse or vandalism, and can sometimes affect other users who are unrelated to that abuse. Review the information below for assistance if you do not believe that you have done anything wrong.

The IP address or range 44.201.0.0/16 has been blocked (disabled) by ‪ST47‬ for the following reason(s):

The IP address that you are currently using has been blocked because it is believed to be a web host provider. To prevent abuse, web hosts may be blocked from editing Wikipedia.
You will not be able to edit Wikipedia using a web host provider because it hides your IP address, much like a proxy or VPN.
We recommend that you attempt to use another connection to edit. For example, if you use a proxy or VPN to connect to the internet, turn it off when editing Wikipedia. If you edit using a mobile connection, try using a Wi-Fi connection, and vice versa. If you are using a corporate internet connection, switch to a different Wi-Fi network. If you have a Wikipedia account, please log in.
If you do not have any other way to edit Wikipedia, you will need to request an IP block exemption.

How to appeal if you are confident that your connection does not use a web host's IP address:
If you are confident that you are not using a web host, you may appeal this block by adding the following text on your talk page: ((unblock|reason=Caught by a web host block but this host or IP is not a web host. My IP address is _______. Place any further information here. ~~~~)). You must fill in the blank with your IP address for this block to be investigated. Your IP address can be determined here. Alternatively, if you wish to keep your IP address private you can use the unblock ticket request system. There are several reasons you might be editing using the IP address of a web host (such as if you are using VPN software or a business network); please use this method of appeal only if you think your IP address is in fact not a web host.

Administrators: The IP block exemption user right should only be applied to allow users to edit using web host in exceptional circumstances, and they should usually be directed to the functionaries team via email. If you intend to give the IPBE user right, a CheckUser needs to take a look at the account. This can be requested most easily at SPI Quick Checkuser Requests. Unblocking an IP or IP range with this template is highly discouraged without at least contacting the blocking administrator.

This block will expire on 23:54, 31 July 2024.

Even when blocked, you will usually still be able to edit your user talk page, as well as email administrators and other editors.

For information on how to proceed, please read the FAQ for blocked users and the guideline on block appeals. The guide to appealing blocks may also be helpful.

Other useful links: Blocking policy · Help:I have been blocked
Your IP address is in a range that has been blocked on all Wikimedia Foundation wikis. The block was made by ‪AntiCompositeNumber‬. The reason given is Open proxy/Webhost: Visit the FAQ if you are affected .
- Start of block: 13:55, 18 August 2022
- Expiry of block: 13:55, 18 April 2025
Your current IP address is 44.201.28.123. The blocked range is 44.201.0.0/16. Please include all above details in any queries you make. If you believe you were blocked by mistake, you can find additional information and instructions in the No open proxies global policy. Otherwise, to discuss the block please post a request for review on Meta-Wiki. You could also send an email to the stewards VRT queue at stewards@wikimedia.org including all above details.

You can view and copy the source of this page:

{| class="wikitable sortable mw-collapsible (({state<includeonly>|mw-collapsed</includeonly>))}" style="margin: 1em auto;"
|+ class="nowrap" | ((Navbar|Parenteral durations of androgens/anabolic steroids|mini=y)) Parenteral durations of <noinclude>[[androgen]]s/[[anabolic steroid]]s</noinclude><includeonly>androgens/anabolic steroids</includeonly>
|-
! Medication !! Form !! Major brand names !! data-sort-type="number" | Duration
|-
| ((No selflink|Testosterone (medication)|Testosterone)) || Aqueous suspension || Andronaq, Sterotate, Virosterone || 2–3&nbsp;days
|-
| ((No selflink|Testosterone propionate)) || Oil solution || style="white-space: nowrap;" | Androteston, Perandren, Testoviron || 3–4&nbsp;days
|-
| ((No selflink|Testosterone phenylpropionate)) || Oil solution || Testolent || 8&nbsp;days
|-
| ((No selflink|Testosterone isobutyrate)) || Aqueous suspension || Agovirin Depot, Perandren M || 14&nbsp;days
|-
| ((No selflink|Testosterone propionate/testosterone valerate/testosterone undecylenate|Mixed testosterone esters))<sup>a</sup> || Oil solution || Triolandren || 10–20&nbsp;days
|-
| ((No selflink|Testosterone propionate/testosterone ketolaurate|Mixed testosterone esters))<sup>b</sup> || Oil solution || Testosid Depot || 14–20&nbsp;days
|-
| ((No selflink|Testosterone enanthate)) || Oil solution || Delatestryl || 14–28&nbsp;days
|-
| ((No selflink|Testosterone cypionate)) || Oil solution || Depovirin || 14–28&nbsp;days
|-
| ((No selflink|Testosterone propionate/testosterone phenylpropionate/testosterone isocaproate/testosterone decanoate|Mixed testosterone esters))<sup>c</sup> || Oil solution || Sustanon 250 || 28&nbsp;days
|-
| ((No selflink|Testosterone undecanoate)) || Oil solution || Aveed, Nebido || 100&nbsp;days
|-
| ((No selflink|Testosterone buciclate))<sup>d</sup> || Aqueous suspension || 20 Aet-1, CDB-1781<sup>e</sup> || style="white-space: nowrap;" | 90–120&nbsp;days
|-
| ((No selflink|Nandrolone phenylpropionate)) || Oil solution || Durabolin || 10&nbsp;days
|-
| ((No selflink|Nandrolone decanoate)) || Oil solution || Deca Durabolin || 21–28&nbsp;days
|-
| ((No selflink|Methandriol)) || Aqueous suspension || Notandron, Protandren || 8&nbsp;days
|-
| ((No selflink|Methandriol bisenanthoyl acetate)) || Oil solution || Notandron Depot || 16&nbsp;days
|-
| ((No selflink|Metenolone acetate)) || Oil solution || Primobolan || 3&nbsp;days
|-
| ((No selflink|Metenolone enanthate)) || Oil solution || Primobolan Depot || 14&nbsp;days
|- class="sortbottom"
| colspan="4" style="width: 1px; background-color:#eaecf0; text-align: center;" | '''Note:''' All are via [[intramuscular injection|((abbr|i.m.|intramuscular)) injection]]. '''Footnotes:''' <sup>a</sup> = ((No selflink|Testosterone propionate|((Abbr|TP|Testosterone propionate)))), ((No selflink|Testosterone valerate|((Abbr|TV|Testosterone valerate)))), and ((No selflink|Testosterone undecylenate|((Abbr|TUe|Testosterone undecylenate)))). <sup>b</sup> = ((No selflink|Testosterone propionate|((Abbr|TP|Testosterone propionate)))) and ((No selflink|Testosterone ketolaurate|((Abbr|TKL|Testosterone ketolaurate)))). <sup>c</sup> = ((No selflink|Testosterone propionate|((Abbr|TP|Testosterone propionate)))), ((No selflink|Testosterone phenylpropionate|((Abbr|TPP|Testosterone phenylpropionate)))), ((No selflink|Testosterone isocaproate|((Abbr|TiCa|Testosterone isocaproate)))), and ((No selflink|Testosterone decanoate|((Abbr|TD|Testosterone decanoate)))). <sup>d</sup> = Studied but never marketed. <sup>e</sup> = Developmental code names. '''Sources:''' <noinclude>''Main:'' <ref name="SchuermannDoepfmer1960">((cite book| first1 = Hans | last1 = Schuermann | first2 = Rudolf | last2 = Doepfmer | name-list-style = vanc |title=Fertilitätsstörungen beim Manne|url=https://books.google.com/books?id=m1iqBgAAQBAJ&pg=PA260|date=1960|publisher=Springer-Verlag|isbn=978-3-642-94784-1|pages=260–))</ref><ref name="Ufer1960">((cite book| first = Joachim | last = Ufer | name-list-style = vanc |title=Hormontherapie in der Frauenheilkunde: Grundlagen und Praxis|url=https://books.google.com/books?id=wcRsAAAAMAAJ|year=1960|publisher=Gruyter|page=153))</ref><ref name="Pschyrembel1968">((cite book| first = Willibald | last = Pschyrembel | name-list-style = vanc |title=Praktische Gynäkologie: für Studierende und Ärzte|url=https://books.google.com/books?id=vVaTnHDFzZ0C&pg=PA600|date=1968|publisher=Walter de Gruyter|isbn=978-3-11-150424-7|page=600))</ref><ref name="WrightBurgess2012">((cite book| first1 = Jeremy C. | last1 = Wright| first2 = Diane J. | last2 = Burgess | name-list-style = vanc |title=Long Acting Injections and Implants|url=https://books.google.com/books?id=36nkGjEGEToC&pg=PA114|date=29 January 2012|publisher=Springer Science & Business Media|isbn=978-1-4614-0554-2|pages=114–))</ref> ''Additional:'' <ref name="Llewellyn2011">((cite book| first = William | last = Llewellyn | name-list-style = vanc |title=Anabolics|url=https://books.google.com/books?id=afKLA-6wW0oC&pg=PT385|year=2011|publisher=Molecular Nutrition Llc|isbn=978-0-9828280-1-4|pages=385–394))</ref><ref name="pmid17486268">((cite journal | vauthors = Saad F, Kamischke A, Yassin A, Zitzmann M, Schubert M, Jockenhel F, Behre HM, Gooren L, Nieschlag E | display-authors = 6 | title = More than eight years' hands-on experience with the novel long-acting parenteral testosterone undecanoate | journal = Asian Journal of Andrology | volume = 9 | issue = 3 | pages = 291–7 | date = May 2007 | pmid = 17486268 | doi = 10.1111/j.1745-7262.2007.00275.x ))</ref><ref name="pmid1430080">((cite journal | vauthors = Behre HM, Nieschlag E | title = Testosterone buciclate (20 Aet-1) in hypogonadal men: pharmacokinetics and pharmacodynamics of the new long-acting androgen ester | journal = The Journal of Clinical Endocrinology and Metabolism | volume = 75 | issue = 5 | pages = 1204–10 | date = November 1992 | pmid = 1430080 | doi = 10.1210/jcem.75.5.1430080 ))</ref><ref name="NieschlagBehre2013">((cite book| first1 = Eberhard | last1 = Nieschlag | first2 = Hermann | last2 = Behre | name-list-style = vanc |title=Andrology: Male Reproductive Health and Dysfunction|url=https://books.google.com/books?id=05fsCAAAQBAJ&pg=PA412|date=29 June 2013|publisher=Springer Science & Business Media|isbn=978-3-662-04491-9|pages=412–|quote=Under the auspices of WHO a synthesis programme identified testosterone buciclate as a testosterone ester with long-lasting effectiveness. First tested in monkeys and then in hypogonadal patients, it showed a long effective phase of 3–4 months after a single injection.))</ref></noinclude><includeonly>See template.</includeonly>
|}<!--

--><noinclude>((Documentation|content=
== See also ==
* [[Template:Parenteral potencies and durations of steroidal estrogens]]
* [[Template:Parenteral potencies and durations of progestogens]]
* [[Template:Structural properties of major testosterone esters]]
* [[Template:Structural properties of major anabolic steroid esters]]
== References ==
((Reflist))
))
[[Category:Medication templates]]
[[Category:Templates that generate named references]]
</noinclude>

Pages transcluded onto the current version of this page (help):

Metenolone acetate (edit)
Metenolone enanthate (edit)
Methandriol (edit)
Methandriol bisenanthoyl acetate (edit)
Nandrolone decanoate (edit)
Nandrolone phenylpropionate (edit)
Testosterone (medication) (edit)
Testosterone buciclate (edit)
Testosterone cypionate (edit)
Testosterone decanoate (edit)
Testosterone enanthate (edit)
Testosterone isobutyrate (edit)
Testosterone isocaproate (edit)
Testosterone ketolaurate (edit)
Testosterone phenylpropionate (edit)
Testosterone propionate (edit)
Testosterone propionate/testosterone ketolaurate (edit)
Testosterone propionate/testosterone phenylpropionate/testosterone isocaproate/testosterone decanoate (edit)
Testosterone propionate/testosterone valerate/testosterone undecylenate (edit)
Testosterone undecanoate (edit)
Testosterone undecylenate (edit)
Testosterone valerate (edit)
Template:Abbr (view source) (protected)
Template:Cite book (view source) (protected)
Template:Cite journal (view source) (protected)
Template:Documentation (view source) (template editor protected)
Template:Hlist/styles.css (view source) (protected)
Template:Main other (view source) (protected)
Template:Navbar (view source) (protected)
Template:No self link (view source) (semi-protected)
Template:No selflink (view source) (semi-protected)
Template:Reflist (view source) (protected)
Template:Reflist/styles.css (view source) (protected)
Module:Arguments (view source) (protected)
Module:Check for unknown parameters (view source) (protected)
Module:Citation/CS1 (view source) (protected)
Module:Citation/CS1/COinS (view source) (protected)
Module:Citation/CS1/Configuration (view source) (protected)
Module:Citation/CS1/Date validation (view source) (protected)
Module:Citation/CS1/Identifiers (view source) (protected)
Module:Citation/CS1/Utilities (view source) (protected)
Module:Citation/CS1/Whitelist (view source) (protected)
Module:Citation/CS1/styles.css (view source) (protected)
Module:Documentation (view source) (template editor protected)
Module:Documentation/config (view source) (template editor protected)
Module:Documentation/styles.css (view source) (template editor protected)
Module:Navbar (view source) (protected)
Module:Navbar/configuration (view source) (protected)
Module:Navbar/styles.css (view source) (protected)
Module:Redirect (view source) (protected)
Module:String (view source) (protected)

Return to Template:Parenteral durations of androgens/anabolic steroids.

Retrieved from "https://en.wikipedia.org/wiki/Template:Parenteral_durations_of_androgens/anabolic_steroids"